A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology
Human parainfluenza virus type 3 (HPIV-3) can cause severe respiratory tract infections. There are no convenient small-animal infection models.
An aberrant immune–epithelial progenitor niche drives viral lung sequela
The long-term physiological consequences of respiratory viral infections, particularly in the aftermath of the COVID-19 pandemic—termed post-acute sequelae of SARS-CoV-2 (PASC)—are rapidly evolving into a major public health concern.
Call to Action: Respiratory virus infections and cardiovascular disease (CVD)
Vaccination against respiratory viruses can reduce the risk of complications associated with CVDs.
What do B- and T-cells do and how do they respond?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
What is the difference between innate and adaptive immune response?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
News
Policy & Recommendations
Joint Statement of the Steering Group on Influenza Vaccination on the Council Conclusions on the Future of the European Health Union: A Europe That Cares, Prepares, and Protects
The Steering Group strongly supports promotion of immunisation and prevention, whilst recognising the need for additional measures to address existing gaps and further enhance the effectiveness of these initiatives
Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain
The objective of this study is to estimate the burden of selected immunization-preventable infectious diseases in Spain.
Defining the balance between optimal immunity and immunopathology in influenza virus infection
Influenza A viruses remain a global threat to human health, with continued pandemic potential.
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
Paving the way to life course immunisation in Europe podcast series
Dr Vytenis Andriukaitis, former European Commissioner and experienced health advocate, discusses with host Gary Finnegan the significance of advocating for vaccination throughout life.
